Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine Extended-Release in Elderly Patients With Epilepsy
NCT00516139Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2007
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lamotrigine in epilepsy, sponsored by GSK. Started Aug 2007; status: completed.
02
Drugs
lamotrigine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00516139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00516139.